Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Maintenance × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5 Lung Neoplasms 2 Neoplasm Metastasis 1 Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 41 Carboplatin 28 Pemetrexed 23 Docetaxel 21 Nivolumab 19 Cisplatin 19 Paclitaxel 17 Gemcitabine 14 Magnetic Resonance Spectroscopy 13 Radiotherapy 12 Specimen Handling 11 Cyclophosphamide 10 Bevacizumab 10 130-nm albumin-bound paclitaxel 10 osimertinib 9 Erlotinib Hydrochloride 9 Radiosurgery 8 Cetuximab 8 Biopsy 7 Temozolomide 6 Ramucirumab 6 Radiation 6 tislelizumab 5 fludarabine 5 durvalumab 5 Trastuzumab 5 Taxes 5 Ipilimumab 5 Gefitinib 5 veliparib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02919462 2018-01-16

HighTySy

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡